Enterprise Ireland is a government agency established in 1998 that focuses on developing and funding indigenous businesses in Ireland. Its mission is to promote the growth of world-class companies in global markets, thereby enhancing national and regional prosperity. The agency manages an Equity Fund with over 2,500 investments, predominantly in technology, life sciences, and general sectors. Enterprise Ireland specializes in direct investments, including private equity and venture capital across various stages from seed to growth capital, while excluding companies involved in gambling. It targets sectors such as digital content, clean technology, and healthcare, and aims to invest in small to medium enterprises based in Ireland and select regions. Additionally, it operates a Fund of Funds program and engages in co-investments with both domestic and international venture and private equity funds. The agency seeks to provide equity and debt financing ranging from €2 million to €10 million to established companies, while preferring to maintain a maximum 10% stake in its portfolio. Enterprise Ireland is headquartered in Dublin, Ireland.

Frontline, established in 2012, is a private equity firm headquartered in London with a presence in Dublin. Specializing in early-stage investments in technology-facing companies, Frontline leverages a combination of capital and experience to support ambitious founders in Europe, bridging the gap between technical expertise and human connections. Through their innovative platform, Frontline aims to harness collective intelligence and provide valuable resources to shorten founders' learning curves. Additionally, the firm invests in building relationships to facilitate expansion into the US market, offering insights and support to reduce friction for companies looking to grow internationally.

The Ireland Strategic Investment Fund, managed by the National Treasury Management Agency, is an €8.5 billion sovereign development fund with a unique mandate to invest on a commercial basis to support economic activity and employment in Ireland. With a long investment horizon and flexibility in the capital structure, the Fund aims to make a positive economic impact by investing in transactions where it can make a difference. As a strategic investor with strong connections in public and private sectors, the Fund drives innovation and fosters partnerships to unlock opportunities for growth and development that might otherwise be overlooked.

Act Venture Capital is a Dublin-based venture capital firm founded in 1994, specializing in seed to growth-stage investments primarily in technology and healthcare sectors across Ireland, the United Kingdom, and Europe. The firm has raised approximately €500 million across multiple funds and focuses on companies with innovative, category-defining potential in areas such as application software, IT infrastructure, communications, and medical devices. Act Venture Capital supports founders in creating and scaling their businesses globally, leveraging a network of over 200 entrepreneurs and investors built over 25 years. The firm typically takes minority stakes in its portfolio companies and often seeks board representation, investing either independently or alongside other venture capital firms. Its most recent funds have received backing from the European Investment Fund.

Foresight Group is an independent alternative asset manager with over 30 years of experience, specializing in environmental and solar infrastructure as well as private equity. With more than £2.2 billion in assets under management, the firm serves a diverse client base that includes private and high-net-worth individuals, family offices, pension funds, and other institutional investors from the UK and internationally. Foresight aims to generate sustainable dividends and capital appreciation for its investors by developing compelling long-term investment strategies. The firm is committed to supporting sustainable economic and social development through its investments. Foresight Group operates offices in the UK, USA, Italy, and Australia.

Atlantic Bridge is a growth equity firm founded in 2004, headquartered in Dublin, with additional offices in London, Palo Alto, Munich, and Paris. The firm specializes in early to mid-stage investments in technology and life sciences, focusing on sectors such as artificial intelligence, machine learning, robotics, and clean technology. Atlantic Bridge targets growth-stage companies primarily in Europe, the United States, and China, aiming to scale these businesses in international markets. The firm typically invests between €5 million and €20 million in companies with revenues ranging from €15 million to €50 million. Its strategy includes taking minority stakes, securing board seats, and pursuing exits through initial public offerings or trade sales within five to eight years. Atlantic Bridge also manages a €60 million University Fund dedicated to supporting entrepreneurs in commercializing innovative research and scaling their ventures. The firm's team comprises experienced technology entrepreneurs and finance professionals who leverage their extensive international business backgrounds to foster successful partnerships and investment outcomes.

IDIA Capital Investissement is the private equity arm of Crédit Agricole Capital Investissement et Finance. The firm specializes in direct and fund of funds investments. Within the fund of funds investments, the firm seeks to invest in private equity and venture capital funds. Within the direct investments, the firm specializes in growth capital, middle market, leveraged buyouts, leveraged buyins, OBO, spin-off, recapitalization, PIPES, and mezzanine financing. It provides financing in the form of combined equity, quasi equity, convertible bonds, and long-term subordinated debt to mid-cap and small and medium size listed and unlisted companies. It does not invest in venture capital and only co-invests in growth capital with a minority or majority stake. The firm primarily invests in food processing, nutrition, food retail, agricultural distribution, catering, agrifood, agriculture, and wine industry, such as wine growing and wine producing. Within agrifood, it invests in Agroindustries and related sectors mainly in mid-cap and in small and medium size companies, investing between €1 million to €50 million in companies with an enterprise value of €15 million to €500 million taking typically minority stake or majority stake in case of co-investments over an average holding period of five to seven years. Within the wine industry, it seeks to take majority and minority stakes in prestigious vineyards with an enterprise value of €5 million to €150 million, investing usually between €5 million to €20 million over an average holding period of seven to twelve years. Within agriculture, it invests in agricultural production, forestry, farming, and vineyard groups. The firm seeks to invest in French and Italian companies. Generally, the firm invests TO_DELETE in companies valued TO_DELETE taking minority as well as majority stake in its portfolio companies and also co-invests alongside other partners. It usually takes a seat on the Board of Directors or in the Strategic Committee of it investee companies. The average investment period is between seven to ten years. IDIA Capital Investissement is based in Montrouge, France with additional offices in Montrouge, France and Milan, Italy.

Speedinvest is a European venture capital firm based in Vienna, Austria, founded in 2011. It focuses on early-stage investments in technology-related companies, targeting sectors such as fintech, insurtech, deep tech, and consumer tech. The firm typically invests between €250,000 and €3 million, aiming for minority stakes of up to 20% in its portfolio companies. Speedinvest emphasizes operational support and seeks to collaborate closely with entrepreneurs, often taking on operational roles for six months to a year. With a network that extends to Silicon Valley, Speedinvest positions itself as a pivotal investment and development hub within Europe’s start-up ecosystem, actively investing in Central and Eastern European markets including Austria, Germany, and the UK.

Crescent Capital is a Belfast-based private equity and venture capital firm established in 1995, focusing on early-stage, development-stage, and growth-oriented investments in Northern Ireland. The firm primarily targets the information technology, life sciences, and manufacturing sectors, investing through equity. Crescent Capital typically makes initial investments ranging from £0.45 million to £1.20 million, with the potential for total investments of up to £3 million per company across all funding rounds. The firm is open to both majority and minority ownership stakes and often seeks a Non-Executive Director position on the boards of its portfolio companies. Crescent Capital aims to exit its investments within five to seven years, often through trade sales.

Kernel Capital is an independent manager of The Bank of Ireland Kernel Capital Venture Funds, recognized as one of the largest and most active sources of equity finance for technology companies on the island of Ireland, covering both the Republic of Ireland and Northern Ireland. The firm has raised over €210 million from a diverse range of investors, including the Bank of Ireland, Invest NI, and various university foundations. Kernel Capital specializes in equity investments across various stages of company growth, focusing on sectors such as information technology, telecommunications, biotechnology, and financial services. It primarily targets knowledge-based companies with strong intellectual property. The firm is notable for its extensive network, which assists portfolio companies in talent acquisition and market expansion. Kernel Capital has consistently achieved strong financial returns and has facilitated over 20 significant trade sales to publicly listed corporations. Founded in 2002, Kernel Capital operates from offices in Cork, Dublin, and Belfast.